Change in KDIGO Kidney Risk Category with Semaglutide Treatment – A Post-Hoc Analysis of the Sustain 6 Trial

Document Type

Abstract

Publication Date

2022

Publication Title

ERA Paris 2022

Keywords

spokane; washington; pmrc

Clinical Institute

Kidney & Diabetes

Department

Endocrinology

This document is currently not available here.


Share

COinS